Serialization solution for Nigeria provides drug authentication and patient communication by text message
As brand protection technology vendors are figuring out how pharma companies can authenticate products and connect with customers through educational or promotional messaging at the same time, Sproxil Inc. (Somerville, MA) proves that it can be done.
With its Mobile Product Authentication (MPA) solution, which it calls “crowd-sourced pharmacovigilance,” Sproxil enables patients to text message an item-unique code found on drug packaging for rapid authentication. In addition to getting the green light on the product, patients receive a text message back from the drug company, which Sproxil says can be customized with disease management tips or ads that target specific demographics.
Other companies are working on drug authentication solutions that allow customer connectivity. Earlier this year, Covectra (Southborough, MA) told Pharmaceutical Commerce that it was implementing its Brand Loyalty and Integrity Service (BLIS) based on AuthentiTrack; Catalent Pharma Solutions (Somerset, NJ) said it was working with DigiMarc Corp. (Beaverton, OR) on “media-enhanced packaging” for use with a smartphone.
Sproxil’s solution is currently being tested in Nigeria, where scratch cards that contain item-unique codes attached to medication packaging are used for authentication.
Sproxil recently was named a finalist in the MITX Technology Awards, which recognize technology advancements made in New England.
“Sproxil is honored to be recognized for our simple, easy-to-use and comprehensive anti-counterfeiting strategy, which can be used anywhere mobile phones exist,” says Sproxil CEO Ashifi Gogo.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.